1Siegel R, Ma J, Zou Z, et al. Cancer sta-tistics, 2014[J]. CA Cancer J Clin, 2014, 64(1): 9-29.
2Sabine VS, Crozier C, Brookes CL, et al. Mutational analysis of pi3k/akt signaling pathway in tamoxifenexemestane adjuvant multinational pathology study[J]. J Clin Oncol, 2014, 32(27): 2951-2958.
3Harder H, Langridge C, Solis-Trapala 1, et al. Post-operative exercises after breast cancer surgery: results of a RCT evaluating standard care versus standard care plus additional yoga exercise[J]. European Journal of Integrative Medicine, 2015,56:157-186.
4Aceto N, Bardia A, Miyamoto DT, et al. Circulating tumor cell clusters are oligoelonal precursors of breast cancer metastasis[J]. Ce[1, 2014, 158(5): 1110-1122.
5Saini KS, Loi S, de Azambuja A, et al. Targeting the pi3k/ Akt/mtor and Raf/mek/erk pathways in the treatment of breast cancer[J]. Cancer Treat Rev, 2013, 39(8): 935-946.
6Boosani CS, Agrawal DK. PTEN modulators: a patent review[J]. Expert Opin Ther Pat, 2013, 23(5): 569-580.
7Wikman H, Lamszus K, Detels N, et al. Relevance of PTEN loss in brain metastasis formation in breast cancer patients[J]. Breast Cancer Res, 2012, 14(2): R49.
8Hurvitz SA, Hu Y, O'Brien N, et al. Current approaches and future directions in the treatment of HER2-positive breast cancer[J]. Cancer Treat Rev, 2013, 39(3): 219-229.
